To authorize director incharge of CDL Kolkata for signing report of test of MD samples sent by Court of Laws

## Policy Analysis Report: Authorization of Director Incharge of Central Drugs Laboratory, Kolkata to Sign Statutory Certificates for Medical Devices **1. Executive Summary:** This report analyzes a notification issued by the Ministry of Health and Family Welfare, Department of Health and Family Welfare, authorizing Dr. Saroj Kumar Ghosh, Director Incharge of Central Drugs Laboratory, Kolkata, to sign statutory certificates of test or evaluation of medical device samples under specific circumstances. This authorization addresses a temporary gap in leadership at the laboratory and ensures continued compliance with the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017. The key finding is the authorization of an individual to perform a critical function ensuring regulatory compliance for medical devices, pending a permanent appointment. **2. Introduction:** This report provides an informative analysis of the notification S.O. 3758(E), dated August 10, 2022, pertaining to the authorization of the Director Incharge of the Central Drugs Laboratory, Kolkata, to sign statutory certificates related to medical devices. This analysis is based solely on the text provided in the notification. **3. Policy Overview:** * This is a *new* directive within the existing regulatory framework. * **Core Objective(s):** The core objective is to ensure the continued validity and processing of statutory certificates for medical device samples submitted by Courts of Law or under Form MD30 of the Medical Devices Rules, 2017, during a period of leadership transition at the Central Drugs Laboratory, Kolkata. **4. Background and Rationale:** This policy addresses a potential disruption in the certification process for medical devices due to a vacancy (or pending permanent appointment) in the Director position at the Central Drugs Laboratory, Kolkata. Without authorization, the statutory certificates could not be legally signed, potentially delaying legal proceedings and regulatory compliance. **5. Key Provisions:** This notification specifically authorizes Dr. Saroj Kumar Ghosh, the Director Incharge of the Central Drugs Laboratory, Kolkata, to sign: * Statutory certificates of test or evaluation of samples of medical devices sent by Courts of Law under subsection 4 of section 25 of the Drugs and Cosmetics Act, 1940. * Certificates in Form MD30 of the Medical Devices Rules, 2017. This authorization is valid: * From the date of publication of the notification (August 10, 2022). * Until a regularly appointed person takes charge of the post, or until further orders, whichever is earlier. **6. Target Audience and Stakeholders:** The target audience and stakeholders directly affected by this policy include: * **Medical Device Manufacturers and Distributors:** Who require these certificates for legal and regulatory compliance. * **Courts of Law:** Which submit medical device samples for testing and evaluation. * **Central Drugs Laboratory, Kolkata:** Specifically the Director Incharge and staff. * **Department of Health and Family Welfare:** Responsible for the oversight of medical device regulation. **7. Implementation Aspects (Inferred):** * **Responsible agency/bodies:** Ministry of Health and Family Welfare, Department of Health and Family Welfare, Central Drugs Laboratory, Kolkata. * **Timelines:** The authorization is effective from the date of publication (August 10, 2022) and lasts until a permanent director is appointed or further orders are issued. * **Procedures:** The Central Drugs Laboratory, Kolkata, will continue to test/evaluate medical devices and issue the required statutory certificates, with Dr. Ghosh now authorized to sign them. **8. Expected Outcomes / Impact of Changes:** The intended outcome of this authorization is to ensure uninterrupted regulatory compliance and legal processes related to medical devices. This includes: * Avoiding delays in court proceedings involving medical devices. * Maintaining the validity of certifications required under the Medical Devices Rules, 2017. * Ensuring a smooth transition in leadership at the Central Drugs Laboratory, Kolkata. **9. Conclusion:** The notification authorizing Dr. Saroj Kumar Ghosh to sign statutory certificates for medical devices during the interim period is a crucial measure to maintain the integrity of the regulatory process. It addresses a potential gap in leadership and ensures the continued enforcement of the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017, thereby safeguarding public health and ensuring compliance within the medical device industry.

Key Entities Referenced